Mimi Kim

Mimi Kim

Auto-generated profile, based on publicly available information

Mimi Kim

Department of Epidemiology & Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JHJohannes Hartl
Johannes Hartl
LSLee Serpas
Lee Serpas
YWYueyang Wang
Yueyang Wang
ARAli Rashidfarrokhi
Ali Rashidfarrokhi
OPOriana A. Perez
Oriana A. Perez
BRBoris Reizis
Boris Reizis
Antibodies to double-stranded DNA (dsDNA) are prevalent in systemic lupus erythematosus (SLE), particularly in patients with lupus nephritis, yet the nature and regulation of antigenic cell-free DNA (cfDNA) are poorly understood. Null mutations in the secreted DNase DNASE1L3 cause human monogenic SLE with anti-dsDNA autoreactivity. We report that >50% of sporadic SLE patients with nephritis manifested reduced DNASE1L3 activity in circulation, which was associated with neutralizing autoantibodies to DNASE1L3. These patients had normal total plasma cfDNA levels but showed accumulation of cfDNA in circulating microparticles. Microparticle-associated cfDNA contained a higher fraction of longer polynucleosomal cfDNA fragments, which bound autoantibodies with higher affinity than mononucleosomal fragments. Autoantibodies to DNASE1L3-sensitive antigens on microparticles were prevalent in SLE nephritis patients and correlated with the accumulation of cfDNA in microparticles and with disease severity. DNASE1L3-sensitive antigens included DNA-associated proteins such as HMGB1. Our results reveal autoantibody-mediated impairment of DNASE1L3 activity as a common nongenetic mechanism facilitating anti-dsDNA autoreactivity in patients with severe sporadic SLE.

1 December 2017 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
XXXiaonan Xue
Xiaonan Xue
IAIlir Agalliu
Ilir Agalliu
MKMimi Y. Kim
Mimi Y. Kim
TWTao Wang
Tao Wang
JLJuan Lin
Juan Lin
HSHoward D. Strickler
Howard D. Strickler
The follow-up rate, a standard index of the completeness of follow-up, is important for assessing the validity of a cohort study. A common method for estimating the follow-up rate, the “Percentage Method”, defined as the fraction of all enrollees who developed the event of interest or had complete follow-up, can severely underestimate the degree of follow-up. Alternatively, the median follow-up time does not indicate the completeness of follow-up, and the reverse Kaplan-Meier based method and Clark’s Completeness Index (CCI) also have limitations. We propose a new definition for the follow-up rate, the Person-Time Follow-up Rate (PTFR), which is the observed person-time divided by total person-time assuming no dropouts. The PTFR cannot be calculated directly since the event times for dropouts are not observed. Therefore, two estimation methods are proposed: a formal person-time method (FPT) in which the expected total follow-up time is calculated using the event rate estimated from the observed data, and a simplified person-time method (SPT) that avoids estimation of the event rate by assigning full follow-up time to all events. Simulations were conducted to measure the accuracy of each method, and each method was applied to a prostate cancer recurrence study dataset. Simulation results showed that the FPT has the highest accuracy overall. In most situations, the computationally simpler SPT and CCI methods are only slightly biased. When applied to a retrospective cohort study of cancer recurrence, the FPT, CCI and SPT showed substantially greater 5-year follow-up than the Percentage Method (92%, 92% and 93% vs 68%). The Person-time methods correct a systematic error in the standard Percentage Method for calculating follow-up rates. The easy to use SPT and CCI methods can be used in tandem to obtain an accurate and tight interval for PTFR. However, the FPT is recommended when event rates and dropout rates are high.


1 February 2012 in Cancer Epidemiology
Verified
Journal Article
Closed access
GKGeoffrey C. Kabat
Geoffrey C. Kabat
MKMimi Y. Kim
Mimi Y. Kim
PWProf. Dr. Jean Wactawski-Wende
Prof. Dr. Jean Wactawski-Wende
JBJennifer W Bea
Jennifer W Bea
KEKerstin L. Edlefsen
Kerstin L. Edlefsen
TRThomas Rohan
Thomas Rohan

3 January 2012 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
GKGeoffrey C. Kabat
Geoffrey C. Kabat
MKMimi Y. Kim
Mimi Y. Kim
CTCynthia Thomson
Cynthia Thomson
JLJuhua Luo
Juhua Luo
JWJean Wactawski-Wende
Jean Wactawski-Wende
TRThomas Rohan
Thomas Rohan

11 October 2005 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
DSDan Sheng
Dan Sheng
MKMimi Y. Kim
Mimi Y. Kim